Make DermaSensor™ Your New Assistant For Skin Cancer Care
We’ve launched the world’s first point-and-click device that brings objective skin cancer assessment to primary care offices. You now have a tool to help evaluate patient skin cancer risk in just seconds.
- Simple design, effortless application
- Objective, simple and immediate result
- Help avoid benign excisions with unnecessary morbidity and poor reimbursement
The DermaSensor device provides GPs with a quick, non-invasive tool to detect skin cancer early, aiding in better patient outcomes, fewer unnecessary excisions, and increased revenue.
Assess the patient's lesions to identify those visually suggestive of skin cancer for which an objective risk assessment would be helpful.
Use DermaSensor to analyze those lesions of concern to receive an "Investigate Further" or "Monitor" result for each lesion
Counsel your patient on next steps, such as further investigating the lesion through a biopsy or specialist referral, or just monitoring the lesion having ruled out the need for an immediate biopsy or referral.